Scholar Rock

@ScholarRock

Clinical-stage biopharma company focused on diseases in which protein growth factors play a fundamental role. Please see our Terms of Use:

Cambridge, MA, USA
Vrijeme pridruživanja: travanj 2015.

Tweetovi

Blokirali ste korisnika/cu @ScholarRock

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ScholarRock

  1. 10. sij
    Poništi
  2. 9. sij

    Scholar Rock Achieves First Milestone in Strategic Fibrosis Collaboration with Gilead Sciences

    Poništi
  3. 20. pro 2019.

    Sharing these creative antibody and logo cookies from Scholar Rock bakers as we wish everyone the sweetest of holidays!

    Poništi
  4. 19. pro 2019.

    The Scholar Rock team embraced the spirit of the holidays, gathering gifts for The Wish Project to give to families in our area.

    Poništi
  5. 19. stu 2019.

    Scholar Rock Reports Preliminary Pharmacokinetic and Pharmacodynamic Data from TOPAZ Phase 2 Trial of SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy

    Poništi
  6. 5. ruj 2019.

    Scholar Rock Announces Appointment of George Nomikos, M.D., Ph.D., as Vice President, Head of Medical Research, Muscle Franchise

    Poništi
  7. 1. ruj 2019.

    One last reminder: The Scholar Rock team is inspired by all families facing and honored to be developing new treatment options for this devastating disease.

    Poništi
  8. 26. kol 2019.
    Poništi
  9. 20. kol 2019.

    Scholar Rock is developing a potential new treatment for Spinal Muscular Atrophy directly targeting the weakening of skeletal muscle, with the goal of increasing muscle strength and motor function. CEO Nagesh Mahanthappa discusses for :

    Poništi
  10. 15. kol 2019.
    Poništi
  11. 14. kol 2019.

    Scholar Rock Reports Second Quarter 2019 Financial Results and Highlights Business Progress

    Poništi
  12. 12. kol 2019.
    Poništi
  13. 8. kol 2019.
    Poništi
  14. 7. kol 2019.
    Poništi
  15. 6. kol 2019.
    Poništi
  16. 2. kol 2019.
    Poništi
  17. 1. kol 2019.

    Today is the start of , and Scholar Rock will join in the efforts to raise awareness about . is a serious, rare disease that usually manifests in infants and children. We're proud to be developing a potential new treatment for SMA.

    Poništi
  18. 15. srp 2019.

    Team Scholar Rock came together today to help Rise Against Hunger lend a hand to people in critical aid need across the globe by packaging 10,000 meals. Learn more here:

    Poništi
  19. 28. lip 2019.

    We are inspired by people and families whose lives have been affected by and excited to be part of researching novel medicines. At , we will present Phase 1 results in HV of SRK-015, a potential muscle-directed therapy (announced June 3).

    Poništi
  20. 27. lip 2019.

    We enjoyed celebrating with a talented group of innovators and leaders at the EY Entrepreneur of the Year New England Awards Gala last night.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·